✦ LIBER ✦

Topical heparin for the treatment of acute superficial phlebitis secondary to indwelling intravenous catheter A double-blind, randomized, placebo-controlled trial

✍ Scribed by M. Villardell; D. Sabat; J. A. Arnaiz; M. J. Bleda; J. M. Castel; J. R. Laporte; C. Vallvé

Book ID: 105922950
Publisher: Springer
Year: 1999
Tongue: English
Weight: 85 KB
Volume: 54
Category: Article
ISSN: 0031-6970
DOI: 10.1007/s002280050575

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adalimumab for the treatment of patients

Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double-blind, randomized, placebo-controlled trial

✍ Philip J. Mease; Dafna D. Gladman; Christopher T. Ritchlin; Eric M. Ruderman; Se 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

A multicenter, prospective, randomized,

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma

✍ Rachel K. Hoyles; Ross W. Ellis; Jessica Wellsbury; Belinda Lees; Pauline Newlan 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

## Abstract ## Objective The lack of randomized controlled trials (RCTs) in pulmonary fibrosis in systemic sclerosis (SSc) has hampered an evidence‐based approach to treatment. This RCT was undertaken to investigate the effects of intravenous (IV) cyclophosphamide (CYC) followed by azathioprine (A

Randomized, double blind, placebo contro

Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy

✍ Stefan K. Plontke; Hubert Löwenheim; Jürgen Mertens; Corinna Engel; Christoph Me 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 384 KB

## Abstract ## Objectives: To study the safety and efficacy of continuous intratympanic dexamethasone‐phosphate (Dex‐P) for severe to profound sudden idiopathic sensorineural hearing (ISSHL) or sudden idiopathic anacusis after failure of systemic therapy. ## Study Design: Randomized, double‐blin

Response to Randomized, Double Blind, Pl

Response to Randomized, Double Blind, Placebo Controlled Trial on the Safety and Efficacy of Continuous Intratympanic Dexamethasone Delivered Via a Round Window Catheter for Severe to Profound Sudden Idiopathic Sensorineural Hearing Loss After Failure of Systemic Therapy (Laryngoscope 119:359–369, 2009)

✍ Stefan K. Plontke; Hubert Löwenheim; Assen Koitschev; Hans-Peter Zenner 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 50 KB

In reference to Randomized, Double Blind

In reference to Randomized, Double Blind, Placebo Controlled Trial on the Safety and Efficacy of Continuous Intratympanic Dexamethasone Delivered Via a Round Window Catheter for Severe to Profound Sudden Idiopathic Sensorineural Hearing Loss After Failure of Systemic Therapy (Laryngoscope 119:359–369, 2009)

✍ Tsutomu Nakashima; Masaaki Teranishi; Tadao Yoshida 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB

A Randomized, Double-Blind, Placebo-Cont

A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Intravenous MCC-135 as an Adjunct to Primary Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction: Rationale and Design of the Evaluation of MCC-135 for Left Ventricular Salvage in Acute MI (EVOLVE) Study

✍ Ik-Kyung Jang; Veronica Pettigrew; Michael H. Picard; Peter R. Kowey; Valentin D 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 219 KB